Related content

Ask the Experts: Pharmacogenomics and genome-wide association studies

By Hakonarson Hakon  

Pharmacogenomics, Vol. 14, Iss. 4, 2013-03 ,pp. : 365-368

Future Medicine

Access to resources Recommend Favorite

Genome-wide studies in pharmacogenomics: harnessing the power of extreme phenotypes

By Gurwitz David   McLeod Howard L  

Pharmacogenomics, Vol. 14, Iss. 4, 2013-03 ,pp. : 337-339

Future Medicine

Access to resources Recommend Favorite

Genome-wide approaches in pharmacogenomics: heritability estimation and pharmacoethnicity as primary challenges

By Gamazon Eric R   Perera Minoli  

Pharmacogenomics, Vol. 13, Iss. 10, 2012-07 ,pp. : 1101-1104

Future Medicine

Access to resources Recommend Favorite

Pharmacogenomics of the response to IFN-&bgr;β in multiple sclerosis: ramifications from the first genome-wide screen

By Vandenbroeck Koen   Matute Carlos  

Pharmacogenomics, Vol. 9, Iss. 5, 2008-05 ,pp. : 639-645

Future Medicine

Access to resources Recommend Favorite

Genome-wide Analysis of Myelodysplastic Syndromes

By  

Current Pharmaceutical Design, Vol. 18, Iss. 22, 2012-07 ,pp. : 3163-3169

Bentham Science Publishers

Access to resources Recommend Favorite